---
document_datetime: 2025-12-29 14:34:19
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/riprazo.html
document_name: riprazo.html
version: success
processing_time: 0.1110381
conversion_datetime: 2025-12-31 03:03:02.885966
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Riprazo

[RSS](/en/individual-human-medicine.xml/66580)

##### Withdrawn

This medicine's authorisation has been withdrawn

aliskiren Medicine Human Withdrawn

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Riprazo](#news-on)
- [More information on Riprazo](#more-information-on-riprazo-1368)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 22 August 2007, the European Commission issued a marketing authorisation valid throughout the European Union for the medicinal product Riprazo, (aliskiren), which had been approved for treatment of essential hypertension. The marketing authorisation holder (MAH) responsible for Riprazo was Novartis Europharm Ltd.

On 24 January 2013, the European Commission issued a decision to withdraw the marketing authorisation for Riprazo, following its receipt of a letter dated 18 December 2012 notifying the Commission of the MAH's decision to voluntarily withdraw the marketing authorisation for this product for commercial reasons. Riprazo was marketed in the following European countries: Spain (until 31 December 2012) and was not marketed in any other European country.

Pursuant to this decision, the European public assessment report for Riprazo is updated to reflect that the marketing authorisation is no longer valid.

Riprazo : EPAR - Summary for the public

English (EN) (187.23 KB - PDF)

**First published:** 07/05/2009

**Last updated:** 20/09/2012

[View](/en/documents/overview/riprazo-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-720)

български (BG) (267.39 KB - PDF)

**First published:**

07/05/2009

**Last updated:**

20/09/2012

[View](/bg/documents/overview/riprazo-epar-summary-public_bg.pdf)

español (ES) (188.34 KB - PDF)

**First published:**

07/05/2009

**Last updated:**

20/09/2012

[View](/es/documents/overview/riprazo-epar-summary-public_es.pdf)

čeština (CS) (236.86 KB - PDF)

**First published:**

07/05/2009

**Last updated:**

20/09/2012

[View](/cs/documents/overview/riprazo-epar-summary-public_cs.pdf)

dansk (DA) (188.88 KB - PDF)

**First published:**

07/05/2009

**Last updated:**

20/09/2012

[View](/da/documents/overview/riprazo-epar-summary-public_da.pdf)

Deutsch (DE) (250.26 KB - PDF)

**First published:**

07/05/2009

**Last updated:**

20/09/2012

[View](/de/documents/overview/riprazo-epar-summary-public_de.pdf)

eesti keel (ET) (187.97 KB - PDF)

**First published:**

07/05/2009

**Last updated:**

20/09/2012

[View](/et/documents/overview/riprazo-epar-summary-public_et.pdf)

ελληνικά (EL) (275.64 KB - PDF)

**First published:**

07/05/2009

**Last updated:**

20/09/2012

[View](/el/documents/overview/riprazo-epar-summary-public_el.pdf)

français (FR) (250.06 KB - PDF)

**First published:**

07/05/2009

**Last updated:**

20/09/2012

[View](/fr/documents/overview/riprazo-epar-summary-public_fr.pdf)

italiano (IT) (192.22 KB - PDF)

**First published:**

07/05/2009

**Last updated:**

20/09/2012

[View](/it/documents/overview/riprazo-epar-summary-public_it.pdf)

latviešu valoda (LV) (242.57 KB - PDF)

**First published:**

07/05/2009

**Last updated:**

20/09/2012

[View](/lv/documents/overview/riprazo-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (217.51 KB - PDF)

**First published:**

07/05/2009

**Last updated:**

20/09/2012

[View](/lt/documents/overview/riprazo-epar-summary-public_lt.pdf)

magyar (HU) (229.63 KB - PDF)

**First published:**

07/05/2009

**Last updated:**

20/09/2012

[View](/hu/documents/overview/riprazo-epar-summary-public_hu.pdf)

Malti (MT) (235.53 KB - PDF)

**First published:**

07/05/2009

**Last updated:**

20/09/2012

[View](/mt/documents/overview/riprazo-epar-summary-public_mt.pdf)

Nederlands (NL) (188.74 KB - PDF)

**First published:**

07/05/2009

**Last updated:**

20/09/2012

[View](/nl/documents/overview/riprazo-epar-summary-public_nl.pdf)

polski (PL) (297.59 KB - PDF)

**First published:**

07/05/2009

**Last updated:**

20/09/2012

[View](/pl/documents/overview/riprazo-epar-summary-public_pl.pdf)

português (PT) (264.01 KB - PDF)

**First published:**

07/05/2009

**Last updated:**

20/09/2012

[View](/pt/documents/overview/riprazo-epar-summary-public_pt.pdf)

română (RO) (218.03 KB - PDF)

**First published:**

07/05/2009

**Last updated:**

20/09/2012

[View](/ro/documents/overview/riprazo-epar-summary-public_ro.pdf)

slovenčina (SK) (278.35 KB - PDF)

**First published:**

07/05/2009

**Last updated:**

20/09/2012

[View](/sk/documents/overview/riprazo-epar-summary-public_sk.pdf)

slovenščina (SL) (228.45 KB - PDF)

**First published:**

07/05/2009

**Last updated:**

20/09/2012

[View](/sl/documents/overview/riprazo-epar-summary-public_sl.pdf)

Suomi (FI) (265.85 KB - PDF)

**First published:**

07/05/2009

**Last updated:**

20/09/2012

[View](/fi/documents/overview/riprazo-epar-summary-public_fi.pdf)

svenska (SV) (249.95 KB - PDF)

**First published:**

07/05/2009

**Last updated:**

20/09/2012

[View](/sv/documents/overview/riprazo-epar-summary-public_sv.pdf)

## Product information

Riprazo : EPAR - Product Information

English (EN) (649.36 KB - PDF)

**First published:** 18/06/2009

**Last updated:** 20/09/2012

[View](/en/documents/product-information/riprazo-epar-product-information_en.pdf)

[Other languages (23)](#file-language-dropdown-215)

български (BG) (902.17 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/bg/documents/product-information/riprazo-epar-product-information_bg.pdf)

español (ES) (619.59 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/es/documents/product-information/riprazo-epar-product-information_es.pdf)

čeština (CS) (789.29 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/cs/documents/product-information/riprazo-epar-product-information_cs.pdf)

dansk (DA) (637.46 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/da/documents/product-information/riprazo-epar-product-information_da.pdf)

Deutsch (DE) (669.55 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/de/documents/product-information/riprazo-epar-product-information_de.pdf)

eesti keel (ET) (654.53 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/et/documents/product-information/riprazo-epar-product-information_et.pdf)

ελληνικά (EL) (996.88 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/el/documents/product-information/riprazo-epar-product-information_el.pdf)

français (FR) (745.35 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/fr/documents/product-information/riprazo-epar-product-information_fr.pdf)

íslenska (IS) (675.49 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/is/documents/product-information/riprazo-epar-product-information_is.pdf)

italiano (IT) (757.31 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/it/documents/product-information/riprazo-epar-product-information_it.pdf)

latviešu valoda (LV) (810.27 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/lv/documents/product-information/riprazo-epar-product-information_lv.pdf)

lietuvių kalba (LT) (759.46 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/lt/documents/product-information/riprazo-epar-product-information_lt.pdf)

magyar (HU) (791.1 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/hu/documents/product-information/riprazo-epar-product-information_hu.pdf)

Malti (MT) (907.63 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/mt/documents/product-information/riprazo-epar-product-information_mt.pdf)

Nederlands (NL) (621.18 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/nl/documents/product-information/riprazo-epar-product-information_nl.pdf)

norsk (NO) (659.16 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/no/documents/product-information/riprazo-epar-product-information_no.pdf)

polski (PL) (843.1 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/pl/documents/product-information/riprazo-epar-product-information_pl.pdf)

português (PT) (721.42 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/pt/documents/product-information/riprazo-epar-product-information_pt.pdf)

română (RO) (689.67 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/ro/documents/product-information/riprazo-epar-product-information_ro.pdf)

slovenčina (SK) (835.24 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/sk/documents/product-information/riprazo-epar-product-information_sk.pdf)

slovenščina (SL) (788.82 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/sl/documents/product-information/riprazo-epar-product-information_sl.pdf)

Suomi (FI) (636.53 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/fi/documents/product-information/riprazo-epar-product-information_fi.pdf)

svenska (SV) (606.45 KB - PDF)

**First published:**

18/06/2009

**Last updated:**

20/09/2012

[View](/sv/documents/product-information/riprazo-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IG/0209/G 17/08/2012

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Riprazo : EPAR - All Authorised presentations

English (EN) (225.29 KB - PDF)

**First published:** 03/09/2007

**Last updated:** 20/09/2012

[View](/en/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_en.pdf)

[Other languages (23)](#file-language-dropdown-673)

български (BG) (248.08 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/bg/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_bg.pdf)

español (ES) (226.23 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/es/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_es.pdf)

čeština (CS) (233.81 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/cs/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (205.62 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/da/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (206.63 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/de/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (207.33 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/et/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (250.29 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/el/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_el.pdf)

français (FR) (209.37 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/fr/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_fr.pdf)

íslenska (IS) (226.53 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/is/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_is.pdf)

italiano (IT) (226.09 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/it/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (216.14 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/lv/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (539.5 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/lt/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (241.81 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/hu/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (235.35 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/mt/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (226.03 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/nl/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (228.5 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/no/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_no.pdf)

polski (PL) (233.81 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/pl/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_pl.pdf)

português (PT) (227.59 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/pt/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_pt.pdf)

română (RO) (228.75 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/ro/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (235.4 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/sk/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (233.41 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/sl/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (228.05 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/fi/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (227.48 KB - PDF)

**First published:**

03/09/2007

**Last updated:**

20/09/2012

[View](/sv/documents/all-authorised-presentations/riprazo-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Riprazo Active substance aliskiren International non-proprietary name (INN) or common name aliskiren Therapeutic area (MeSH) Hypertension Anatomical therapeutic chemical (ATC) code C09XA02

### Pharmacotherapeutic group

Agents acting on the renin-angiotensin system

### Therapeutic indication

Treatment of essential hypertension.

## Authorisation details

EMA product number EMEA/H/C/000853 Marketing authorisation holder

Novartis Europharm Ltd.

Novartis Europharm Limited

Marketing authorisation issued 22/08/2007 Withdrawal of marketing authorisation 24/01/2013 Revision 8

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Riprazo : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (615.62 KB - PDF)

**First published:** 18/06/2009

**Last updated:** 20/09/2012

[View](/en/documents/procedural-steps-after/riprazo-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Riprazo-H-C-853-A20-69 : EPAR - Assessment Report - Article 20

Adopted

Reference Number: EMA/CHMP/391141/2012

English (EN) (580.88 KB - PDF)

**First published:** 20/09/2012

**Last updated:** 20/09/2012

[View](/en/documents/variation-report/riprazo-h-c-853-a20-69-epar-assessment-report-article-20_en.pdf)

Riprazo-H-C-853-WS-37 : EPAR - Assessment Report - Variation

Adopted

Reference Number: EMA/CHMP/479605/2012

English (EN) (2.97 MB - PDF)

**First published:** 20/09/2012

**Last updated:** 20/09/2012

[View](/en/documents/variation-report/riprazo-h-c-853-ws-37-epar-assessment-report-variation_en.pdf)

Riprazo-H-C-853-WS-169 : EPAR - Assessment Report - Variation

Adopted

Reference Number: EMA/CHMP/479606/2012

English (EN) (347.5 KB - PDF)

**First published:** 20/09/2012

**Last updated:** 20/09/2012

[View](/en/documents/variation-report/riprazo-h-c-853-ws-169-epar-assessment-report-variation_en.pdf)

Riprazo-H-C-853-WS-69 : EPAR - Assessment Report - Variation

Adopted

Reference Number: EMA/74385/2012

English (EN) (250.95 KB - PDF)

**First published:** 01/03/2012

**Last updated:** 01/03/2012

[View](/en/documents/variation-report/riprazo-h-c-853-ws-69-epar-assessment-report-variation_en.pdf)

## Initial marketing authorisation documents

Riprazo : EPAR - Scientific Discussion

English (EN) (755.14 KB - PDF)

**First published:** 15/10/2008

**Last updated:** 15/10/2008

[View](/en/documents/scientific-discussion/riprazo-epar-scientific-discussion_en.pdf)

Riprazo : EPAR - Procedural steps taken before authorisation

English (EN) (144.23 KB - PDF)

**First published:** 03/09/2007

**Last updated:** 03/09/2007

[View](/en/documents/procedural-steps/riprazo-epar-procedural-steps-taken-authorisation_en.pdf)

#### News on Riprazo

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 February 2012](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-13-16-february-2012) 17/02/2012

[European Medicines Agency recommends new contraindications and warnings for aliskiren-containing medicines](/en/news/european-medicines-agency-recommends-new-contraindications-warnings-aliskiren-containing-medicines) 17/02/2012

[European Medicines Agency starts review of aliskiren-containing medicines following termination of ALTITUDE study](/en/news/european-medicines-agency-starts-review-aliskiren-containing-medicines-following-termination-altitude-study) 22/12/2011

[European Medicines Agency recommends new contraindication and warning for Rasilez and other aliskiren medicines](/en/news/european-medicines-agency-recommends-new-contraindication-warning-rasilez-other-aliskiren-medicines) 19/02/2009

#### More information on Riprazo

Questions and answers on the review aliskiren-containing medicines

Reference Number: EMA/113677/2012

English (EN) (60.98 KB - PDF)

**First published:** 17/02/2012

**Last updated:** 17/02/2012

[View](/en/documents/medicine-qa/questions-and-answers-review-aliskiren-containing-medicines_en.pdf)

Questions and answers on ongoing review of aliskiren-containing medicines

Reference Number: EMA/990270/2011

English (EN) (65.3 KB - PDF)

**First published:** 22/12/2011

**Last updated:** 22/12/2011

[View](/en/documents/medicine-qa/questions-and-answers-ongoing-review-aliskiren-containing-medicines_en.pdf)

**This page was last updated on** 01/03/2013

## Share this page

[Back to top](#main-content)